<!DOCTYPE html>
<!--[if IE 8 ]&gt;&lt;html lang="en" class="no-js ie8"&gt; &lt;![endif]-->
<!--[if IE 9 ]&gt;&lt;html lang="en" class="no-js ie9"&gt; &lt;![endif]-->
<!--[if (gt IE 9)|!(IE)]&gt;&lt;!-->
<html class="no-js" lang="en">
 <!--&lt;![endif]-->
 <head>
  <meta charset="utf-8"/>
  <meta content="IE=edge;FF=3;OtherUA=4" http-equiv="X-UA-Compatible"/>
  <meta content="width=device-width, initial-scale=1" name="viewport"/>
  <meta content="2StwmRgp7puWeLFMHHlrI9by2UuNVI6cINHgmMt/DnE=" name="verify-v1"/>
  <meta content="lF2XmR7++FsOf3CyD9GjzBP13ECmLbzN3zvcBm22h8M=" name="verify-v1"/>
  <meta content="Vy2WQqSVx1yA90Uu2Rw12f2R8yqP7X0cxBFbafIuqao=" name="verify-v1"/>
  <meta content="0uwxbLV_H5lccP3wm0UgRXFQ9w6ZQXh9ZLn-G0av8i0" name="google-site-verification"/>
  <title>
   OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug | Medpage Today
  </title>
  <link href="http://www.medpagetoday.com/HematologyOncology/Myeloma/47355" rel="canonical"/>
  <meta content="yes" name="apple-mobile-web-app-capable"/>
  <meta content="Use of reduced-nicotine cigarettes did not increase smoking intensity or exposure to tobacco toxins among smokers who did not intend to quit, a prospective clinical study showed." name="description"/>
  <script language="javascript" src="http://clf2.medpagetoday.com/assets/scripts/js/horizon.js?" type="text/javascript">
  </script>
  <link href="http://www.medpagetoday.com/upload/2014/8/25/47355.jpg" rel="image_src"/>
  <meta content="Summary" name="twitter:card"/>
  <meta content="http://www.medpagetoday.com/HematologyOncology/Myeloma/47355" name="twitter:url"/>
  <meta content="OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug" name="twitter:title"/>
  <meta content="Use of reduced-nicotine cigarettes did not increase smoking intensity or exposure to tobacco toxins among smokers who did not intend to quit, a prospective clinical study showed." name="twitter:description"/>
  <meta content="http://www.medpagetoday.com/upload/2014/8/25/47355.jpg" name="twitter:image"/>
  <meta content="http://www.medpagetoday.com/HematologyOncology/Myeloma/47355" property="og:url"/>
  <meta content="OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug" property="og:title"/>
  <meta content="Use of reduced-nicotine cigarettes did not increase smoking intensity or exposure to tobacco toxins among smokers who did not intend to quit, a prospective clinical study showed." name="og:description"/>
  <meta content="article" property="og:type"/>
  <meta content="http://www.medpagetoday.com/upload/2014/8/25/47355.jpg" property="og:image"/>
  <meta content="lungcancer,prostatecancer,hematologyoncology,infectiousdisease,primarycare,pulmonology,urology,surgery,hematology,othercancers,smoking,generalsurgery,generalinfectiousdisease,generalprimarycare,myeloma,oncology,anesthesiology,nursing,nursing" name="sailthru.tags"/>
  <meta content="OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug" name="sailthru.title"/>
  <meta content="Charles  Bankhead  " name="sailthru.author"/>
  <meta content="2014-08-25 13:30:00" name="sailthru.date"/>
  <meta content="2014-08-25 13:30:00" name="date"/>
  <meta content="2014-08-25 13:30:00" name="dc.date.issued"/>
  <meta content="2014-08-25 13:30:00" name="dc.date"/>
  <meta content="2014-08-26 13:08:00" name="sailthru.expire_date"/>
  <meta content="1" name="sailthru.exclude"/>
  <meta content="Use of reduced-nicotine cigarettes did not increase smoking intensity or exposure to tobacco toxins among smokers who did not intend to quit, a prospective clinical study showed." name="sailthru.description"/>
  <meta content="1" name="sailthru.featured"/>
  <meta content="infectiousdiseases,primarycare,anesthesiology,hematologyoncology,pulmonarymedicine,surgery,urology" name="sailthru.speciality"/>
  <meta content="1" name="sailthru.is_cme"/>
  <meta content="0" name="sailthru.is_video"/>
  <meta content="http://www.medpagetoday.com/upload/2014/8/25/47355.jpg" name="sailthru.image.full"/>
  <script src="//cdn.optimizely.com/js/576710981.js">
  </script>
  <link href="http://clf1.medpagetoday.com/assets/scripts/css/article/style.css?v=6.18" rel="stylesheet"/>
  <link href="http://clf1.medpagetoday.com/assets/scripts/css/globalHeader.css?v=6.18" rel="stylesheet"/>
  <link href="http://clf1.medpagetoday.com/assets/scripts/css/global/regwall/regwall.css?v=6.18" rel="stylesheet"/>
  <link href="http://clf1.medpagetoday.com/assets/images/static/favicon.ico?v=1" rel="icon"/>
  <link href="http://clf1.medpagetoday.com/assets/images/static/favicon.ico?v=1" rel="shortcut icon"/>
  <script src="http://tracking.waterfrontmedia.com/GCScript.ashx?p=233" type="text/javascript">
  </script>
  <script type="text/javascript">
   (function() {window.MPT = {};window.MPT.tbid = [47355];window.MPT.adZone = 'hematologyoncology/myeloma';
    window.MPT.isCME = '1';window.MPT.ct = 'articleimage';window.MPT.catvalue = 'cat=lungcancer;cat=prostatecancer;cat=hematologyoncology;cat=infectiousdisease;cat=primarycare;cat=pulmonology;cat=urology;cat=surgery;cat=hematology;cat=othercancers;cat=smoking;cat=generalsurgery;cat=generalinfectiousdisease;cat=generalprimarycare;cat=myeloma;cat=oncology;cat=anesthesiology;cat=nursing;cat=nursing;';
    window.MPT.inViewAds=1;window.MPT.viewability=1;window.MPT.adRefreshRate=6000000;
    ga_acct="UA-3717434-1";})();
  </script>
  <script src="http://clf1.medpagetoday.com/assets/scripts/js/article/head.js?v=6.18">
  </script>
  <!--[if lt IE 9]&gt;&lt;script language="javascript" type="text/javascript" src="http://clf1.medpagetoday.com/assets/scripts/js/html5.js?v=6.18"&gt;&lt;/script&gt;&lt;![endif]-->
 </head>
 <body data-pagetype="article">
  <div id="siteWrapper">
   <div id="mptNav">
   </div>
   <div id="mptContainer">
    <div id="mptHeader">
     <div class="mptHdr-wrapper">
      <div class="mptHdr-module" id="mptSermoBar">
       <div class="sermo-bar mptHdr-wrapper">
        <div class="sermo-inner">
         <div class="sermo-logo">
         </div>
         <a href="#">
          Return to the discussions on Sermo
         </a>
        </div>
       </div>
      </div>
      <div class="mptHdr-module" id="mptUserBar">
       <div class="mptHdr-wrapper">
        <div class="mptHdr-block socialLinks">
         <h4>
          Connect with Us
         </h4>
         <ul>
          <li>
           <a class="icon-rss" href="/About/RSS/">
            RSS
           </a>
          </li>
          <li>
           <a class="icon-facebook" href="https://www.facebook.com/MedPageToday" target="_blank">
            Facebook
           </a>
          </li>
          <li>
           <a class="icon-twitter" href="https://twitter.com/medpagetoday" target="_blank">
            Twitter
           </a>
          </li>
          <li>
           <a class="icon-google" href="https://plus.google.com/115219751345146892459/posts" target="_blank">
            Google+
           </a>
          </li>
          <li>
           <a class="icon-linkedin" href="http://www.linkedin.com/company/104951" target="_blank">
            LinkedIn
           </a>
          </li>
         </ul>
        </div>
        <div class="mptHdr-block accountLogin">
         <div class="mptHdr-panel account-info">
          <span class="account-login">
           <a href="/#!/show/loginPopup">
            Log In
           </a>
           <span>
            or
           </span>
           <a href="/#!/show/account-register">
            <span class="button btn signup">
             Sign Up
            </span>
           </a>
           <a href="/#!/show/loginPopup">
            <span class="userIcon">
             Log In
            </span>
           </a>
          </span>
          <span class="account-profile">
           <a href="/#!/show/profilePopup">
            <span class="account-username">
            </span>
            <span class="userIcon">
             View Profile
            </span>
           </a>
           <span class="alertIndex">
           </span>
          </span>
         </div>
         <div class="" id="mptUserPanels">
          <div class="mptHdr-modalPop loginPopup">
           <div class="loginPanel">
            <div class="mptHdr-loginFields" id="login_fields">
             <div class="error-msg">
              There was no record for this email and password. Please try again.
             </div>
             <p class="modalPop-title">
              Log in to MedPage Today
             </p>
             <input id="loginemail" placeholder="email address" type="email"/>
             <input id="loginpwd" placeholder="password" type="password"/>
             <button class="loginbutton">
              Log in
             </button>
             <a class="forgotPassword" href="/#!/show/forgotPW">
              Forgot your password?
             </a>
            </div>
            <div class="registerPanel">
             <p class="modalPop-title">
              Not a member?
             </p>
             <button class="loginButton registerFree">
              Register FREE
             </button>
            </div>
           </div>
           <div class="forgotPWPanel" id="forgot_password">
            <div class="mptHdr-loginFields">
             <div class="forgoterror error-msg">
             </div>
             <p class="modalPop-title">
              Forgot your password?
             </p>
             <p>
              Enter the email associated with your account and we will send you an email with a link to reset it.
             </p>
             <input class="forgotpwdemail" placeholder="email address" type="email"/>
             <div class="loginButtonsWrapper">
              <button class="modalPop-button forgotpwd">
               Submit
              </button>
              <button class="modalPop-button forgotcnl">
               Cancel
              </button>
             </div>
            </div>
           </div>
          </div>
          <div class="mptHdr-modalPop profilePopup">
          </div>
         </div>
         <div aria-hidden="true" aria-labelledby="Register for free" class="mptModal modal fade" id="register-dialog" role="dialog" tabindex="-1">
          <div class="modal-dialog">
           <div class="modal-content">
            <div class="modal-body">
            </div>
           </div>
          </div>
         </div>
         <div id="register-thanks">
         </div>
        </div>
       </div>
      </div>
      <div class="mptHdr-module" id="mptNavBar">
       <div class="mptHdr-wrapper">
        <div class="mptHdr-block siteBranding">
         <div class="mptHdr-control visible-mobileOnly">
          <a class="button-toggleNav" href="/#!/show/mobileMenu">
           <span class="icon-bar">
           </span>
           <span class="icon-bar">
           </span>
           <span class="icon-bar">
           </span>
          </a>
         </div>
         <div class="mptHdr-branding mptLogo">
          <a href="/">
           <!--[if (gte IE 9)|!(IE)]&gt;&lt;!-->
           <img alt="Medpage Today" class="mptNav_logo-svg" src="http://clf1.medpagetoday.com/assets/images/MPT_logo_transparent.svg"/>
           <!--&lt;![endif]-->
           <!--[if lt IE 9]&gt;&lt;img class="mptNav_logo-png" src="http://clf1.medpagetoday.com/assets/images/logo_desktop.png" alt="Medpage Today" /&gt;&lt;![endif]-->
          </a>
         </div>
        </div>
        <div class="mptHdr-block siteMainNav">
         <div class="mptNav-wrapper" id="mptSiteNav">
          <div class="mptNav-panel mptNav-panel_open default">
           <h3 class="mptNav-logo mptNav-titleBar visible-mobileOnly">
            <a href="/">
             <img alt="Medpage Today" class="mptNav_logo-initials" src="http://clf1.medpagetoday.com/assets/images/logo_MPT-abbreviated.svg"/>
            </a>
           </h3>
           <div class="mptNav-mainLinks">
            <ul class="mptNav-links">
             <li>
              <a href="/Latest/">
               News
              </a>
             </li>
             <li>
              <a href="/HealthPolicy/">
               Health Policy
              </a>
             </li>
             <li>
              <a class="icon-submenu_arrow mptNav-submenu_link" href="/#!/show/specialties">
               Specialties
               <i>
               </i>
              </a>
             </li>
             <li>
              <a href="/CME/">
               Education
              </a>
             </li>
             <li>
              <a class="icon-submenu_arrow mptNav-submenu_link" href="/#!/show/quicktakes">
               Quick Takes
               <i>
               </i>
              </a>
             </li>
            </ul>
           </div>
          </div>
          <div class="mptNav-panel mptNav-specialties submenu_drawer" id="specialties">
           <div class="mptNav-panel-inner">
            <h3 class="mptNav-submenu_back mptNav-titleBar">
             Specialties
            </h3>
            <div class="mptNav-wrapper">
             <ul class="mptNav-links">
              <li>
               <a href="/AllergyImmunology">
                Allergy &amp; Immunology
               </a>
              </li>
              <li>
               <a href="/Anesthesiology">
                Anesthesiology
               </a>
              </li>
              <li>
               <a href="/Cardiology">
                Cardiovascular
               </a>
              </li>
              <li>
               <a href="/CriticalCare">
                Critical Care
               </a>
              </li>
              <li>
               <a href="/Dermatology">
                Dermatology
               </a>
              </li>
              <li>
               <a href="/EmergencyMedicine">
                Emergency Medicine
               </a>
              </li>
              <li>
               <a href="/Endocrinology">
                Endocrinology
               </a>
              </li>
              <li>
               <a href="/Gastroenterology">
                Gastroenterology
               </a>
              </li>
              <li>
               <a href="/Genetics">
                Genetics
               </a>
              </li>
              <li>
               <a href="/Geriatrics">
                Geriatrics
               </a>
              </li>
              <li>
               <a href="/HIVAIDS">
                HIV/AIDS
               </a>
              </li>
              <li>
               <a href="/HospitalBasedMedicine">
                Hospital-Based Medicine
               </a>
              </li>
              <li>
               <a href="/InfectiousDisease">
                Infectious Disease
               </a>
              </li>
              <li>
               <a href="/Nephrology">
                Nephrology
               </a>
              </li>
              <li>
               <a href="/Neurology">
                Neurology
               </a>
              </li>
              <li>
               <a href="/nursing">
                Nursing
               </a>
              </li>
              <li>
               <a href="/OBGYN">
                OB/Gyn
               </a>
              </li>
              <li>
               <a href="/HematologyOncology">
                Oncology/Hematology
               </a>
              </li>
              <li>
               <a href="/Ophthalmology">
                Ophthalmology
               </a>
              </li>
              <li>
               <a href="/Orthopedics">
                Orthopedics
               </a>
              </li>
              <li>
               <a href="/PainManagement">
                Pain Management
               </a>
              </li>
              <li>
               <a href="/Pathology">
                Pathology
               </a>
              </li>
              <li>
               <a href="/Pediatrics">
                Pediatrics
               </a>
              </li>
              <li>
               <a href="/PrimaryCare">
                Primary Care
               </a>
              </li>
              <li>
               <a href="/Psychiatry">
                Psychiatry
               </a>
              </li>
              <li>
               <a href="/Pulmonology">
                Pulmonology
               </a>
              </li>
              <li>
               <a href="/Radiology">
                Radiology
               </a>
              </li>
              <li>
               <a href="/Rheumatology">
                Rheumatology
               </a>
              </li>
              <li>
               <a href="/Surgery">
                Surgery
               </a>
              </li>
              <li>
               <a href="/Transplantation">
                Transplantation
               </a>
              </li>
              <li>
               <a href="/Urology">
                Urology
               </a>
              </li>
             </ul>
            </div>
           </div>
          </div>
          <div class="mptNav-quicktakes mptNav-panel submenu_drawer" id="quicktakes">
           <div class="mptNav-panel-inner">
            <h3 class="mptNav-submenu_back mptNav-titleBar">
             Quick Takes
            </h3>
            <div class="mptNav-wrapper">
             <ul class="mptNav-links">
              <li>
               <a href="/And-Now-a-Word">
                And Now a Word ...
               </a>
              </li>
              <li>
               <a href="/PatientCenteredMedicalHome">
                Building the Patient-Centered Medical Home
               </a>
              </li>
              <li>
               <a href="/CelebrityDiagnosis">
                Celebrity Diagnosis
               </a>
              </li>
              <li>
               <a href="/ConversationsWith">
                Conversations With
               </a>
              </li>
              <li>
               <a href="/DiabetesDiscovery">
                Diabetes Discovery
               </a>
              </li>
              <li>
               <a href="/DrWes">
                Dr. Wes
               </a>
              </li>
              <li>
               <a href="/EPMonthly">
                Emergency Physicians Monthly
               </a>
              </li>
              <li>
               <a href="/FocusonPolicy">
                Focus on Policy
               </a>
              </li>
              <li>
               <a href="/FromtheEditors">
                From the Editors
               </a>
              </li>
              <li>
               <a href="/GarySchwitzer">
                Gary Schwitzer
               </a>
              </li>
              <li>
               <a href="/IltifatHusain">
                iMedicalApps
               </a>
              </li>
              <li>
               <a href="/InOtherWords">
                InOtherWords
               </a>
              </li>
              <li>
               <a href="/IvanToday">
                Ivan Today
               </a>
              </li>
              <li>
               <a href="/KevinMD">
                Kevin, M.D.
               </a>
              </li>
              <li>
               <a href="/PracticePointers">
                Practice Pointers
               </a>
              </li>
              <li>
               <a href="/PulmCCMCentral">
                PulmCCM Central
               </a>
              </li>
              <li>
               <a href="/SHADOWFAX">
                SHADOWFAX
               </a>
              </li>
              <li>
               <a href="/SpecialReports">
                Special Reports
               </a>
              </li>
              <li>
               <a href="/Surveys">
                Surveys
               </a>
              </li>
              <li>
               <a href="/TheGuptaGuide">
                The Gupta Guide
               </a>
              </li>
              <li>
               <a href="/OnHealth">
                Tim Johnson, MD: On Health
               </a>
              </li>
             </ul>
            </div>
           </div>
          </div>
         </div>
        </div>
        <div class="mptHdr-block siteSearch">
         <form action="/search/" id="mptSiteSearch" role="search">
          <input class="searchField" name="q" type="search"/>
          <input class="icon-search" type="submit"/>
          <input class="icon-cancel" type="reset"/>
         </form>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div class="mptNav-holdLayout">
    </div>
    <div id="mptNav-eventBlock">
    </div>
    <main class="mainContent main-content">
     <section class="article-wrap">
      <div class="top-content">
       <div class="top-ad-wrap is-fixed no-tablet" data-sticky="true">
        <div class="top-ad ad-slot tablet-ad mobile-slot-hide ad-1 desktop-ad">
        </div>
       </div>
       <section class="category-top top-banner-fixed">
        <div class="category-top-inner">
         <span class="category-cme">
          cme/ce
         </span>
         <span class="category-primary">
          <a href="/HematologyOncology">
           Oncology/Hematology
          </a>
         </span>
         <time>
          08.25.2014
         </time>
         <a class="comments" data-comment="47355" data-title="OncoBriefs%3A+Low-Nicotine+Cigs%2C+Prostate+Bx+and+UTI%2C+Myeloma+Drug" href="javascript:">
          <span class="count">
           0
          </span>
          Comments
         </a>
        </div>
       </section>
      </div>
      <article>
       <header>
        <h1>
         OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug
        </h1>
       </header>
       <div class="article-inner">
        <div class="article-content">
         <ul class="social-set no-tablet" data-sticky="true">
          <li class="save-btn">
           <a class="icon-plus" href="#" title="Save this article">
            <span>
             save
            </span>
            <span class="response">
             saved
            </span>
           </a>
          </li>
          <li>
           <a class="icon-facebook share" href="https://www.facebook.com/sharer/sharer.php?u=http://www.medpagetoday.com/HematologyOncology/Myeloma/47355&amp;tOncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug" title="Share this article on Facebook">
           </a>
          </li>
          <li>
           <a class="icon-twitter share" href="https://twitter.com/intent/tweet?original_referer=http://www.medpagetoday.com/HematologyOncology/Myeloma/47355&amp;source=tweetbutton&amp;text=OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug&amp;url=http://www.medpagetoday.com/HematologyOncology/Myeloma/47355" title="Tweet this article">
           </a>
          </li>
          <li>
           <a class="icon-linkedin share" href="http://www.linkedin.com/shareArticle?mini=true&amp;url=http://www.medpagetoday.com/HematologyOncology/Myeloma/47355&amp;title=OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug&amp;source=MedpageToday" title="Share this article on Linkedin">
           </a>
          </li>
          <li>
           <a class="icon-mail" href="mailto:?subject=MedPage Today News: OncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug&amp;body=I thought you would like to read the attached article:%0D%0A%0D%0AOncoBriefs: Low-Nicotine Cigs, Prostate Bx and UTI, Myeloma Drug%0D%0A%0D%0AClick http://www.medpagetoday.com/HematologyOncology/Myeloma/47355 for the full story:%0D%0A%0D%0ASign up at http://www.medpagetoday.com/updateProfile.cfm?action=register for your FREE, once-daily, Medical News Daily Headlines Email.%0D%0A%0D%0AMedPage Today(R) provides physicians and 'expert patients' real-time coverage of breaking medical news and the top stories in health and medicine. Physicians, PAs, Nurses, and Pharmacists may also receive CME/CE credit as part of our news coverage.%0D%0A%0D%0AOur content is reviewed and accredited by Projects in Knowledge. Projects in Knowledge is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide CME for physicians.There is no cost to use the service. Visit MedPage Today www.medpagetoday.com now.%0D%0A%0D%0AAt MedPage Today, we are Putting Breaking Medical News into Practice(R)." title="Email a link to this page">
           </a>
          </li>
          <li>
           <a class="icon-print print" href="" title="Print this article.">
           </a>
          </li>
         </ul>
         <ul class="cme-units">
          <li class="cme-join">
           <p class="eyebrow">
            register today
           </p>
           <p>
            Earn Free CME Credits by reading the latest medical news in your specialty.
           </p>
           <a href="#">
            sign up
           </a>
          </li>
         </ul>
         <div class="top-media">
          <div class="top-media-inner single-image">
           <img src="http://www.medpagetoday.com/upload/2014/8/25/47355.jpg"/>
          </div>
         </div>
         <ul class="info-bar">
          <li class="author-img">
           <a href="">
            <img alt="author name" src="http://clf1.medpagetoday.com/assets/images/author/small_Charles_Bankhead_2013.jpg"/>
           </a>
          </li>
          <li class="author-desc ">
           <h2>
            <span>
             by
            </span>
            <a href="mailto:c.bankhead@medpagetoday.com">
             Charles  Bankhead
            </a>
            <br/>
            <i>
             Staff Writer, MedPage Today
            </i>
           </h2>
          </li>
         </ul>
         <div class="body-content">
          <div class="tablet-ad-wrap-container">
           <div class="ad-slot ad-right tablet-ad" id="tablet-ad-47355">
           </div>
           <div class="action-points">
            <div class="ap-heading">
             <h4>
              Action Points
             </h4>
            </div>
            <div class="ap-content">
             <ul>
              <li>
               Note that a small study of reduced-nicotine cigarettes did not show evidence of a compensatory increase in cigarette consumption.
              </li>
              <li>
               Note that a Swedish study suggests a higher-than-anticipated risk of urinary tract infection following prostate biopsy.
              </li>
             </ul>
             <div class="drawer">
              <span class="icon-arrow" href="">
              </span>
             </div>
            </div>
           </div>
          </div>
          <p>
           Use of reduced-nicotine cigarettes did not increase smoking intensity or exposure to tobacco toxins among smokers who did not intend to quit, a prospective clinical study showed.
          </p>
          <p>
           The findings add to existing evidence that reduced-nicotine cigarettes does not adversely affect smokers' consumption behavior, as reported online in
           <a href="http://cebp.aacrjournals.org/content/early/2014/08/15/1055-9965.EPI-13-0957.abstract" target="_blank">
            <em>
             Cancer Epidemiology, Biomarkers &amp; Prevention
            </em>
           </a>
           . The study is one of several news items in this edition of OncoBriefs.
          </p>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <div class="ad-slot ad-left desktop-ad">
          </div>
          <p>
           <strong>
            No Obvious Hazards with Reduced-Nicotine Cigarettes
           </strong>
          </p>
          <p>
           Although the FDA has authority to require lower concentrations of nicotine in cigarettes, some concern has arisen about the possibility that lower nicotine content will lead to increased smoking intensity and exposure to toxins in cigarette tobacco.
          </p>
          <p>
           The effects of reduced-nicotine cigarettes on smoking behavior and toxin exposure was evaluated in 72 adult smokers. Participants completed a 7-day baseline period when they smoked their usual brand of cigarettes, containing approximately 1.2 mg of nicotine, reported
           <a href="https://uwaterloo.ca/public-health-and-health-systems/people-profiles/david-hammond" target="_blank">
            David Hammond, PhD
           </a>
           , of the University of Waterloo in Ontario, and
           <a href="https://www.roswellpark.edu/richard-oconnor" target="_blank">
            Richard J. O'Connor, PhD
           </a>
           , of Roswell Park Cancer Institute in Buffalo, N.Y. The study continued with consecutive 7-day periods of smoking cigarettes with increasingly lower nicotine levels (0.6, 0.3, and 0.05 mg emission).
          </p>
          <p>
           Investigators assessed each participant for nicotine dependence and withdrawal, smoking behavior, and exposure biomarkers during each 7-day period.
          </p>
          <p>
           The results showed that nicotine intake decreased significantly during the 2 weeks the participants smoked the cigarettes with the lowest nicotine concentration, but not during the week the 0.6 mg cigarettes were smoked. Investigators observed no significant changes in smoking behavior or in any of the laboratory parameters assessed.
          </p>
          <div class="ad-slot ad-left tablet-ad">
          </div>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <div class="ad-slot ad-right desktop-ad">
          </div>
          <p>
           "The findings provide little evidence of compensatory smoking of [reduced-nicotine] cigarettes, with no increases in exhaled breath carbon monoxide levels, smoking intensity, or levels of 1-hydroxypyrene across study periods," Hammond and O'Connor wrote in conclusion. "No significant differences were observed for smoking urges or measures of nicotine dependence."
          </p>
          <p>
           "The study adds to the evidence that cigarettes with markedly reduced nicotine content are not associated with increased smoking intensity or exposure to smoke toxicants," they added.
          </p>
          <p>
           <strong>
            Growing Infection Risk with Prostate Biopsy
           </strong>
          </p>
          <p>
           The incidence of urinary tract infection (UTI) tripled in the first month after prostate biopsy, according to a 5-year study from Sweden.
          </p>
          <p>
           From a background UTI rate of 2%, the incidence jumped to 6%, as reflected in prescriptions by antibiotic prescriptions for UTI,
           <a href="http://www.surgsci.umu.se/english/sections/urology-and-andrology/staff/?uid=kalu0015&amp;guiseId=214069&amp;orgId=c70d12cf5b86835d3325763a167e1555d86c15c5&amp;name=Karl-Johan%20Lundstr%C3%B6m" target="_blank">
            Karl-Johan Lundstrom
           </a>
           , of stersund Hospital, and co-authors reported in the
           <a href="http://www.jurology.com/article/S0022-5347%2814%2903517-4/abstract" target="_blank">
            <em>
             Journal of Urology
            </em>
           </a>
           . Overall, antibiotic prescription rate decreased from 2006 to 2011, but infection-related hospitalization increased.
          </p>
          <div class="tablet-ad-wrap-container">
           <div class="ad-slot ad-right tablet-ad">
           </div>
           <div class="ad-slot ad-right tablet-ad">
           </div>
          </div>
          <div class="ad-slot ad-right desktop-ad">
          </div>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <p>
           Prostate biopsy with transrectal ultrasound (TRUS) guidance remains the standard for detecting prostate cancer, but has recognized risk of adverse effects that include febrile UTI and urosepsis, which occur despite prophylactic antibiotics. Previous studies have placed the risk at 1% to 4%.
          </p>
          <p>
           Lundstrom and colleagues sought to evaluate the risk of infectious complications after TRUS-guided prostate biopsy using what they described as the unique metric of post-biopsy antibiotic prescription rate, hospitalization within 30 days of biopsy, and infection-specific mortality.
          </p>
          <p>
           The analysis included 51,321 men identified through Sweden's national prostate cancer database as having newly diagnosed prostate cancer during 2006 to 2011. Primary outcomes were antibiotic prescriptions for UTI and hospitalization associated with a discharge diagnosis of UTI. Investigators used multivariable analysis to determine risk factors for UTI in men undergoing prostate biopsy.
          </p>
          <p>
           In the 6 months prior to prostate biopsy, the men had a UTI rate of 2%. In the first 30 days after biopsy, 6% of the men had a prescription for antibiotics used to treat UTI. Moreover, 1% of the men had hospitalizations related to UTI.
          </p>
          <p>
           The multivariable analysis showed that independent risk factors for post-biopsy UTI were prior infection (OR 1.59, 95% CI 1.45-1.73), Charlson index (OR 1.25, 1.11-1.41), and diabetes (OR 1.32, 1.17-1.49).
          </p>
          <div class="ad-slot ad-right tablet-ad">
          </div>
          <div class="ad-slot ad-right desktop-ad">
          </div>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <p>
           The likelihood of an antibiotic prescription for UTI in the first 30 days after biopsy decreased over the study period (OR 0.79, 0.70-0.90), but the risk of risk of UTI-related hospitalization more than doubled (OR 2.14, 1.58-2.94). The 90-day mortality did not change during the 5-year period.
          </p>
          <p>
           <strong>
            Favorable Results with Investigational Myeloma Drug
           </strong>
          </p>
          <p>
           Treatment with an investigational oral proteasome inhibitor led to stable disease or better response in three fourths of patients with heavily pretreated multiple myeloma.
          </p>
          <p>
           The activity of ixazomib in 60 patients consisted partial or better response in 15% and stable disease in 60%. Hematologic and nonhematologic adverse events were common, but grade 3/4 toxicity was limited to thrombocytopenia (37%) and neutropenia (14%),
           <a href="http://www.dana-farber.org/Health-Library/Paul-Richardson,-MD.aspx" target="_blank">
            Paul Richardson, MD
           </a>
           , of Dana-Farber Cancer Institute in Boston, and co-authors reported in
           <a href="http://www.bloodjournal.org" target="_blank">
            <em>
             Blood
            </em>
           </a>
           .
          </p>
          <p>
           Experience with bortezomib (Velcade) previously demonstrated the effectiveness of the proteasome inhibitor class in the disease. More recently, carfilzomib (Kyprolis) entered the market as a proteasome inhibitor option for patients with relapsed myeloma.
          </p>
          <div class="ad-slot ad-right tablet-ad">
          </div>
          <div class="ad-slot ad-right desktop-ad">
          </div>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <p>
           Several investigational proteasome inhibitors are in development, and ixazomib is the first orally available agent in the class to begin clinical evaluation. Richardson and co-authors reported findings from a phase I dose-finding study.
          </p>
          <p>
           Patients in the trial had received a median of four prior myeloma regimens. In the dose-escalation phase of the trial, 26 patients received 0.24 to 2.23 mg/m
           <sup>
            2
           </sup>
           doses of ixazomib twice a week. An additional 34 patients were enrolled in an expansion cohort treated with 2.0 mg/m
           <sup>
            2
           </sup>
           twice weekly, as well as six patients who received 2.0 mg/m
           <sup>
            2
           </sup>
           during the dose-escalation phase.
          </p>
          <p>
           One patient treated at the highest dose met the definition of dose-limiting toxicity: grade 3 macular erythematous rash, and 2.0 mg/m
           <sup>
            2
           </sup>
           twice a week was identified as the maximum tolerated dose.
          </p>
          <p>
           The study population included 53 patients each who had received bortezomib and/or carfilzomib, 37 who had received lenalidomide (Revlimid), and 34 who had undergone stem cell transplantation. Additionally, 34 patients had proven refractory to their most recent therapy, including 16 who were bortezomib refractory.
          </p>
          <p>
           Grade 3 drug-related adverse events occurred in 37 patients and drug-related grade 4 adverse events in 16. The most frequently reported drug-related adverse events were nausea (25 patients), thrombocytopenia (25), fatigue (24), skin and related disorders (24), vomiting (15), diarrhea (14), pyrexia (12), and neutropenia (11).
          </p>
          <div class="ad-slot ad-right tablet-ad">
          </div>
          <div class="ad-slot ad-left desktop-ad">
          </div>
          <div class="ad-slot ad-right mobile-ad">
          </div>
          <p>
           <strong>
            Surgery Alone an Option for Early Testicular Cancer?
           </strong>
          </p>
          <p>
           Active surveillance after orchiectomy for clinical stage I testis cancer led to "excellent results," according to results of a long-term retrospective cohort study.
          </p>
          <p>
           During a median follow-up of 63 months and almost 2,500 patients, 19% of stage I
           <a href="http://www.nlm.nih.gov/medlineplus/ency/article/001288.htm" target="_blank">
            nonseminomatous tumors
           </a>
           relapsed as did 13% of seminomas. Median time to relapse was 4 months for nonseminomas with lymphovascular invasion, 8 months for nonseminomas without lymphovascular invasion, and 14 months for stage I seminomas.
          </p>
          <p>
           More than 90% of relapses occurred within 2 to 3 years after orchiectomy,
           <a href="http://medicine.med.ubc.ca/profiles/christian-kollmannsberger/" target="_blank">
            Christian Kollmannsberger, MD
           </a>
           , of the British Columbia Cancer Agency in Vancouver, and co-authors reported online in the
           <a href="http://jco.ascopubs.org" target="_blank">
            <em>
             Journal of Clinical Oncology
            </em>
           </a>
           .
          </p>
          <p>
           Although most patients with clinical stage I testicular cancer are cured by surgery alone, postoperative management options include adjuvant chemotherapy, retroperitoneal lymphadenectomy, adjuvant radiation therapy, and active surveillance. With effective therapy as a "safety net," all of the approaches lead to near-100% cure rates, the authors noted.
          </p>
          <div class="ad-slot ad-left tablet-ad">
          </div>
          <div class="ad-slot ad-left mobile-ad">
          </div>
          <p>
           Given the favorable prognosis for stage I testicular cancer, emphasis has shifted to minimizing postoperative morbidity. Active surveillance has become the preferred approach to management for many patients after orchiectomy, the authors continued. However, data on patterns of recurrence and subsequent treatment remain limited.
          </p>
          <p>
           Kollmannsberger and colleagues analyzed multicenter data from institutions and regions that have standardized approaches to management of testicular cancer. The analysis included 2,483 patients with clinical stage I testicular cancer (1,139 nonseminoma cancer and 1,344 seminomas) diagnosed from 1983 to 2012 and managed by active surveillance following orchiectomy.
          </p>
          <p>
           In the nonseminoma group, 90% of relapses met criteria for good risk. Of 1,123 patients who were alive, 98% were disease free. Three patients died of testicular cancer, two from treatment-related complications, and 11 of causes unrelated to testicular cancer.
          </p>
          <p>
           In the seminoma group, all but two relapses were classified as good risk. No patient died of testicular cancer, and 99% remained alive and disease free, the authors reported.
          </p>
          <div style="clear:both;">
          </div>
          <div class="disclaimer">
           <p>
            The study reported by Hammond and O'Connor was supported by the Health Canada Tobacco Control Program, Canadian Institutes of Health Research, and Canadian Cancer Society Research Institute.
           </p>
           <p>
            Hammond disclosed no relevant relationships. O'Connor disclosed that he has provided expert testimony on behalf of the FDA.
           </p>
           <p>
            The study reported by Lundstrom et al was supported by the Swedish Research Council, Swedish Cancer Foundation, Vasterbotten County Council, Lion's Cancer Research Foundation, and the Percy Falk Foundation.
           </p>
           <p>
            Lundstrom disclosed no relevant relationships with industry. Co-author Stacy Loeb disclosed a relevant relationship with Sanofi.
           </p>
           <p>
            The study reported by Richardson et al was supported by Takeda, and co-authors include Takeda employees.
           </p>
           <p>
            Richardson disclosed relevant relationships with Celgene, Janssen, Millennium, and Takeda. One or co-authors disclosed relevant relationships with Millennium, Takeda, Celgene, Novartis, Bristol-Myers Squibb, Sanofi, Karyopharm, Centocor Ortho Biotech, Exelixis, Onyx, and Merck.
           </p>
           <p>
            Kollmannsberger disclosed no relevant relationships with industry. Co-author Tom Powles disclosed relevant relationships with GlaxoSmithKline, Pfizer, and Astellas Pharma.
           </p>
          </div>
          <ul class="secondary-info-bar">
           <li class="reviewed-by">
            <span>
             Reviewed by
            </span>
            <a href="http://www.medpagetoday.com/reviewer.cfm?reviewerid=755">
             F. Perry Wilson, MD, MSCE
            </a>
            Assistant Professor, Section of Nephrology, Yale School of Medicine                                      	and Dorothy Caputo, MA, BSN, RN, Nurse Planner
           </li>
          </ul>
          <p class="last-updated">
           last updated
           <time>
            08.26.2014
           </time>
          </p>
          <div class="sources">
           <ul>
            <li>
             <h4>
              Primary Source
             </h4>
             <h5>
              Cancer Epidemiology, Biomarkers &amp; Prevention
             </h5>
             <a href="http://cebp.aacrjournals.org/content/early/2014/08/15/1055-9965.EPI-13-0957.abstract">
              <span>
               Source Reference:
              </span>
              Hammond D, O'Connor RJ "Reduced-nicotine cigarettes: Smoking behavior and biomarkers of exposure among smokers not intending to quit"
              <em>
               Cancer Epidemiol Biomarkers Prev
              </em>
              2014; DOI:10.1158/1055-9965.EPI-13-0957.
             </a>
            </li>
            <li>
             <h4>
              Secondary Source
             </h4>
             <h5>
              Journal of Urology
             </h5>
             <a href="http://www.jurology.com/article/S0022-5347%2814%2903517-4/abstract">
              <span>
               Source Reference:
              </span>
              Lundstrom K-J et al "Nationwide population-based study of infections after transrectal ultrasound-guided prostate biopsy"
              <em>
               J Urol
              </em>
              2014; DOI: 10.1016/j.juro.2014.04.098.
             </a>
            </li>
            <li>
             <h4>
              Additional Source
             </h4>
             <h5>
              Blood
             </h5>
             <a href="">
              <span>
               Source Reference:
              </span>
             </a>
             <a href="http://www.bloodjournal.org/content/124/7/1038?sso-checked=true" target="_blank">
              Richardson PG et al "Phase I study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients"
              <em>
               Blood
              </em>
              . 2014; 124: 1038-1046.
             </a>
             <p>
              <b>
               Additional source:
              </b>
              Journal of Clinical Oncology
              <br/>
              <a href="">
               <span>
                Source Reference:
               </span>
              </a>
              <a href="http://jco.ascopubs.org/content/early/2014/08/14/JCO.2014.56.2116.abstract" target="_blank">
               Kollmannsberger C, et al "Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance"
               <em>
                J Clin Oncol
               </em>
               2014; DOI: 10.1200/JCO.2014.56.2116.
              </a>
             </p>
            </li>
           </ul>
          </div>
          <div class="post-article-buttons">
           <a class="posttest-btn" href="/posttest_eval.cfm?tbid=47355" rel="nofollow">
            take posttest
           </a>
           <a class="primary-comment-btn" data-comment="47355" data-title="OncoBriefs%3A+Low-Nicotine+Cigs%2C+Prostate+Bx+and+UTI%2C+Myeloma+Drug" href="javascript:">
            <em class="comment-count">
             0
            </em>
            comments
           </a>
          </div>
         </div>
        </div>
        <aside class="sidebar">
         <div class="desktop-ad ad-slot ad-3">
         </div>
         <div class="module popular" data-sticky="true">
          <h3>
           POPULAR IN YOUR SPECIALTY
          </h3>
          <ul>
           <li>
            <p class="eyebrow">
             <time>
              06.24.15
             </time>
             <a href="/HematologyOncology/homepage">
              Oncology/Hematology
             </a>
            </p>
            <h4 class="title">
             <a href="/HematologyOncology/SkinCancer/52275">
              Viagra and Melanoma: Is There a Link?
             </a>
            </h4>
           </li>
           <li>
            <p class="eyebrow">
             <time>
              06.23.15
             </time>
             <a href="/HematologyOncology/homepage">
              Oncology/Hematology
             </a>
            </p>
            <h4 class="title">
             <a href="/HematologyOncology/BreastCancer/52265">
              Cryopreservation Helps Breast CancerPatients Conceive After Treatment
             </a>
            </h4>
           </li>
           <li>
            <p class="eyebrow">
             <time>
              06.23.15
             </time>
             <a href="/HematologyOncology/homepage">
              Oncology/Hematology
             </a>
            </p>
            <h4 class="title">
             <a href="/HematologyOncology/CervicalCancer/52258">
              Fewer Young Women Diagnosed With Cervical Ca
             </a>
            </h4>
           </li>
          </ul>
          <div class="desktop-ad is-locked-ad ad-slot ad-6">
          </div>
         </div>
         <div class="loader">
          Next Article
         </div>
         <div class="popupinter modal">
         </div>
         <footer class="pageFooter">
          <div class="footerInner clearfix">
           <div class="footerLeft">
            <a href="http://corporate.everydayhealth.com/" target="_blank">
             <div class="brand">
             </div>
            </a>
            <p class="headline">
             MedPageToday is a trusted and reliable source for clinical and policy coverage that directly affects the lives and practices of health care professionals.
            </p>
            <p class="about">
             Physicians and other healthcare professionals may also receive Continuing Medical Education (CME) and Continuing Education (CE) credits at no cost for participating in MedPage Today-hosted educational activities.
            </p>
            <p class="footerDisclaimer">
              2015 MedPage Today, LLC. All rights reserved. Use of this site constitutes acceptance of the MedPageToday.com
             <a href="/About/Terms/">
              terms of use
             </a>
             and
             <a href="/About/Privacy/">
              privacy policy
             </a>
             . The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.
            </p>
           </div>
           <div class="footerRight">
            <ul class="footerNav clearfix">
             <li>
              <a href="/About/About/">
               About
              </a>
             </li>
             <li>
              <a href="/About/faq/">
               Help Center
              </a>
             </li>
             <li>
              <a href="/About/sitemap/">
               Site Map
              </a>
             </li>
             <li>
              <a href="http://corporate.everydayhealth.com/advertise-with-us/default.aspx">
               Advertise with Us
              </a>
             </li>
            </ul>
           </div>
          </div>
         </footer>
        </aside>
       </div>
      </article>
     </section>
    </main>
   </div>
   <div class="loading-div">
   </div>
   <script type="text/javascript">
    var MTIProjectId='87a26b72-86c7-4479-adf3-cf1d37bd3e46';
		 (function() {
		        var mtiTracking = document.createElement('script');
		        mtiTracking.type='text/javascript';
		        mtiTracking.async='true';
		        mtiTracking.src=('https:'==document.location.protocol?'https:':'http:')+'//fast.fonts.net/t/trackingCode.js';
		        (document.getElementsByTagName('head')[0]||document.getElementsByTagName('body')[0]).appendChild( mtiTracking );
		   })();
		 window['optimizely'] = window['optimizely'] || [];
		 window['optimizely'].push("activateSiteCatalyst");
   </script>
   <script src="http://clf1.medpagetoday.com/assets/scripts/js/article/libs.js?v=6.18">
   </script>
   <script src="http://clf1.medpagetoday.com/assets/scripts/js/global/regwall/regwall-global.js?v=6.18">
   </script>
   <script src="http://clf1.medpagetoday.com/assets/scripts/js/globalHeader.js?v=6.18">
   </script>
   <script src="http://clf1.medpagetoday.com/assets/scripts/js/article/app.js?v=6.18">
   </script>
   <script async="" src="http://b.scorecardresearch.com/beacon.js" type="text/javascript">
   </script>
   <script type="text/javascript">
    var WRInitTime=(new Date()).getTime(); var _comscore = _comscore || [];_comscore.push({c1: "2",c2: "6035818",  c4: location.hostname + location.pathname})
   </script>
  </div>
 </body>
</html>